University researchers are examining how surgery and aging can specifically affect older brains and how aging brains could recover.

LexBio and Hiteck partner to develop novel drug candidates using AI-driven molecular glue degraders targeting B- and ...

New model blends simplicity, predictability, and early earnings momentum for modern entrepreneurs Network marketing is ...

Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...

A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...

A team of chemists led by Northwestern University has resolved a structural mystery that lingered for roughly three decades, ...

Researchers have identified a potential new treatment for peripheral artery disease (PAD), a condition that causes chronic ...